To measure functional decline we used a questionnaire developed by the German NeuroAIDS Association (DNAA) consisting of twenty-two yes-no questions intended to evaluate neurological abnormalities such as memory and motor impairment, depression and similar problems in HIV-positive patients.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}